Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015.
Acute coronary syndromes
Quality
Taiwan
Journal
Acta Cardiologica Sinica
ISSN: 1011-6842
Titre abrégé: Acta Cardiol Sin
Pays: China (Republic : 1949- )
ID NLM: 101687085
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
5
2
2019
pubmed:
5
2
2019
medline:
5
2
2019
Statut:
ppublish
Résumé
Patients with acute coronary syndrome (ACS), including ST segment elevation myocardial infarction (STEMI) and non-ST segment elevation (NSTE)-ACS have a significant risk of morbidity and mortality. This study evaluated the practice patterns of ACS care in Taiwan from 2005 to 2018. Data from two nationwide ACS registries (2008-2010 and 2012-2015) were used. ACS patients who received percutaneous coronary interventions (PCIs) during admission were compared between the two registries. In STEMI, the door-to-balloon time for primary PCI decreased by 25 min from a median of 96 to 71 min (p < 0.0001) from the first to second registry. More complex PCI procedures and drug-eluting stents were used for ACS. However, the onset-to-door time was still long for both STEMI and NSTE-ACS. The D2B time for NSTE-ACS was long, especially in the elderly and female patients. Although the prescription rate of secondary preventive medications for ACS increased, it was still relatively low compared with Western data, especially in NSTE-ACS. The registry data showed that ACS care quality has improved in Taiwan. However, areas including onset-to-door time and use of secondary preventive medications still need further improvements.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with acute coronary syndrome (ACS), including ST segment elevation myocardial infarction (STEMI) and non-ST segment elevation (NSTE)-ACS have a significant risk of morbidity and mortality. This study evaluated the practice patterns of ACS care in Taiwan from 2005 to 2018.
METHODS
METHODS
Data from two nationwide ACS registries (2008-2010 and 2012-2015) were used. ACS patients who received percutaneous coronary interventions (PCIs) during admission were compared between the two registries.
RESULTS
RESULTS
In STEMI, the door-to-balloon time for primary PCI decreased by 25 min from a median of 96 to 71 min (p < 0.0001) from the first to second registry. More complex PCI procedures and drug-eluting stents were used for ACS. However, the onset-to-door time was still long for both STEMI and NSTE-ACS. The D2B time for NSTE-ACS was long, especially in the elderly and female patients. Although the prescription rate of secondary preventive medications for ACS increased, it was still relatively low compared with Western data, especially in NSTE-ACS.
CONCLUSIONS
CONCLUSIONS
The registry data showed that ACS care quality has improved in Taiwan. However, areas including onset-to-door time and use of secondary preventive medications still need further improvements.
Identifiants
pubmed: 30713394
doi: 10.6515/ACS.201901_35(1).20180716B
pmc: PMC6342842
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1-10Références
Acta Cardiol Sin. 2017 Jul;33(4):329-338
pubmed: 29033503
Int J Clin Pract. 2012 Jan;66(1):69-76
pubmed: 22171906
Am Heart J. 2006 Jan;151(1):206-12
pubmed: 16368320
Circulation. 2011 Aug 30;124(9):1038-45
pubmed: 21859971
Am Heart J. 2010 Jun;159(6):1012-9
pubmed: 20569714
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140
pubmed: 23256914
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Int J Cardiol. 2016 Apr 15;209:103-13
pubmed: 26889592
J Am Coll Cardiol. 2010 Apr 6;55(14):1416-24
pubmed: 20359590
N Engl J Med. 2009 May 21;360(21):2165-75
pubmed: 19458363
J Am Coll Cardiol. 2016 May 24;67(20):2378-2391
pubmed: 27199062
JACC Cardiovasc Interv. 2014 Jan;7(1):55-63
pubmed: 24332419
Int Heart J. 2016 Sep 28;57(5):541-6
pubmed: 27581671
N Engl J Med. 2013 Sep 5;369(10):901-9
pubmed: 24004117
BMJ. 2012 May 23;344:e3257
pubmed: 22623632
Heart Vessels. 2014 Mar;29(2):142-8
pubmed: 23508307
Cardiovasc Interv Ther. 2013 Jan;28(1):30-6
pubmed: 22983884
Int J Cardiol. 2007 Sep 14;121(1):127-9
pubmed: 17107726
J Am Coll Cardiol. 2010 Jul 27;56(5):407-13
pubmed: 20650362
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):126-33
pubmed: 22235068
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):524-32
pubmed: 20031889
BMJ Qual Saf. 2013 Aug;22(8):626-38
pubmed: 23457371
J Am Coll Cardiol. 2013 Aug 6;62(6):496-504
pubmed: 23747778
J Am Heart Assoc. 2014 Aug 11;3(4):
pubmed: 25112555
Acta Cardiol Sin. 2020 Jul;36(4):285-307
pubmed: 32675921
JAMA. 2000 Jul 5;284(1):60-7
pubmed: 10872014
Lancet. 2015 Mar 21;385(9973):1114-22
pubmed: 25467573
Am J Cardiol. 2011 May 15;107(10):1430-5
pubmed: 21414598
Am J Public Health. 2016 Mar;106(3):449-52
pubmed: 26794173
J Korean Med Sci. 2012 Aug;27(8):864-9
pubmed: 22876051
Acta Cardiol Sin. 2016 Jan;32(1):39-48
pubmed: 27122929